EcoDrugPlus

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSSLUG00000005943
Gene Symbol: GRM2
1 Cross references
207 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSSLUG00000024152
Gene Symbol: GRM4
1 Cross references
207 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSSLUG00000024781
Gene Symbol: GRM4
1 Cross references
196 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSSLUG00000010926
Gene Symbol: LOC116056010
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSSLUG00000014397
Gene Symbol: LOC116034713
3 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSSLUG00000002964
Gene Symbol: GRIA1A
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2a

Ensembl ID : ENSSLUG00000005145
Gene Symbol: GRIA2A
1 Cross references
242 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3a

Ensembl ID : ENSSLUG00000025468
Gene Symbol: GRIA3A
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSSLUG00000014807
Gene Symbol: GRIN2BB
1 Cross references
250 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSSLUG00000023313
Gene Symbol: GRM5A
1 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSSLUG00000008667
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSSLUG00000016606
Gene Symbol: GLSA
1 Cross references
228 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).